Blood-derived extracellular vesicles (EVs) hold strong diagnostic potential, yet conventional methods such as ultracentrifugation (UC) and size-exclusion chromatography (SEC) struggle to efficiently separate EVs from lipoproteins and plasma proteins due to overlapping biophysical properties. Manual workflows further introduce operator-dependent variability, limiting reproducibility and hindering clinical translation. This study presents the Vesicle Disk (VDisk), an EV purification platform using centrifugal microfluidics that combines cation exchange chromatography (CEX), sequential filtration (SeqF), and multimodal chromatography (MMC) for efficient, label-free EV isolation from up to 1 mL plasma. Various VDisk configurations with different filter membranes and plasma volumes (0.1– 1.0 mL) were benchmarked against SEC for recovery, purity, reproducibility and robustness. VDisk achieved up to 84.3% EV recovery, surpassing SEC (60.0%), with excellent reproducibility (CV < 5%) and consistent performance under both fasting and postprandial sampling conditions. VDisk offers application-specific flexibility: For applications requiring high EV concentrations, processing up to 1 mL of plasma yields a two to three times higher EV concentration compared to SEC. For purity-critical applications, processing 0.1–0.5 mL of plasma achieves approximately two times higher EV/total protein ratio. These results establish VDisk as an automated, robust, scalable, and adaptable alternative to existing EV isolation methods, suitable for both research and clinical applications.
Small extracellular vesicles (sEV) are membrane-enclosed nanoparticles found in body fluids that carry molecular cargo from their cells of origin. Their stability and disease-associated molecular signatures make them promising targets for the development of non-, or minimally invasive liquid biopsies, yet scalable approaches enabling single-vesicle quantification of sEV while resolving their heterogeneity remain limited. Here, we present PICO (Protein Interaction Coupling), a reference-free quantitative assay adapted for sensitive multiplex profiling of individual intact vesicles. PICO detects vesicle markers by requiring colocalization of two or more copies of the same protein or of distinct proteins (e.g., CD9 or CD9/CD63) on individual vesicles, using DNA-barcoded antibodies and digital PCR (dPCR) for quantitative readout. We demonstrate that this unique architecture of the assay provides high specificity by distinguishing EV-bound proteins from soluble counterparts, and can be adapted to target either surface-exposed or intravesicular biomarkers. PICO requires minimal sample input (1 µl) and no specialized instrumentation beyond standard digital PCR. In a head-to-head comparison with nano-flow cytometry, PICO achieved a comparable limit of detection for sEV subpopulations. Profiling sEV isolates from blood for canonical markers (CD9, CD63 and CD81) and HER2 demonstrates precise, high-resolution quantification of sEV subpopulations in complex clinical samples and supports integration of scalable single-EV analysis into research and diagnostic workflows.